$TEMTempus AI, Inc. · AI software
Tempus AI (TEM) Next Earnings Date & AI Catalysts
AI-powered precision-medicine diagnostics and data.
NEXT EARNINGS
Not yet on our calendar
We add dates once a source publishes them.
Profile
Shares outstanding
Not shown (multiple share classes or no recent cover-page figure)
Not shown (multiple share classes or no recent cover-page figure)
Industry (SEC SIC)
Services-Computer Programming, Data Processing, Etc.
Services-Computer Programming, Data Processing, Etc.
AI angle
Tempus combines genomic testing with a large clinical data set and AI models for diagnostics and drug development.
Key metrics
Revenue (latest quarter) $411.5M
10-Q period ended 2026-09-30; +23% y/y · SEC filing
Operating income -$56.9M
Same quarter; -14% operating margin · SEC filing
Net income -$14.9M
Same quarter · SEC filing
Key risks (from filings)
- “We have incurred significant losses since inception, we may continue to incur losses in the future, and we may not be able to generate sufficient revenue to achieve and maintain…” — 10-K risk factor (filed 2026-02-24) · source
- “If we cannot compete successfully with our competitors, we may be unable to increase or sustain our revenue or to achieve and then sustain profitability.” — 10-K risk factor (filed 2026-02-24) · source
Upcoming catalysts for $TEM
No upcoming catalysts tracked yet.
Recent catalysts
Mon, Nov 2, 2026
Nov
2
Tempus AI, Inc. reports quarterly results
AI-driven diagnostics; a pure-play AI healthcare name. Revenue: $411.5M (+23% y/y), per 10-Q.
Source: sec.gov · Revenue figure: SEC filing
Upcoming earnings
Recap of $TEM's next earnings date — same expected / confirmed labeling as above.
No upcoming earnings date on our calendar yet.